MARKET

CLSDQ

CLSDQ

Clearside
OTCPK
0.600
-0.050
-7.69%
Closed 15:45 02/09 EST
OPEN
0.600
PREV CLOSE
0.650
HIGH
0.605
LOW
0.600
VOLUME
2.42K
TURNOVER
1.45K
52 WEEK HIGH
16.80
52 WEEK LOW
0.320
MARKET CAP
3.14M
P/E (TTM)
-0.1187
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLSDQ last week (0202-0206)?
Weekly Report · 23h ago
Weekly Report: what happened at CLSDQ last week (0126-0130)?
Weekly Report · 02/02 10:20
Weekly Report: what happened at CLSDQ last week (0119-0123)?
Weekly Report · 01/26 10:20
New Strong Sell Stocks for January 21st
NASDAQ · 01/21 09:51
Weekly Report: what happened at CLSDQ last week (0112-0116)?
Weekly Report · 01/19 10:26
Weekly Report: what happened at CLSDQ last week (0105-0109)?
Weekly Report · 01/12 10:25
Weekly Report: what happened at CLSDQ last week (1229-0102)?
Weekly Report · 01/05 10:19
Clearside Biomedical Advances Bankruptcy Asset Sale Process
TipRanks · 12/29/2025 11:35
More
About CLSDQ
Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). The Company's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. The Company is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company's lead program, CLS-AX (axitinib injectable suspension), for the treatment of neovascular age-related macular degeneration (wet AMD). It developed and gained approval for its product, XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the United States through a commercial partner.

Webull offers Clearside Biomedical Inc stock information, including OTCPK: CLSDQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLSDQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLSDQ stock methods without spending real money on the virtual paper trading platform.